Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Epidemiological Study to Determine the Variation in the Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer (PROS-PROSQoLI Study)

NCT02853409 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT02853409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02853409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Epidemiological Study to Determine the Variation in the Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer (PROS-PROSQoLI Study)
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2015
Enrollment
628 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer